Distinct Profiles of Myositis-specific Autoantibodies in Chinese and Japanese Patients with Polymyositis/dermatomyositis

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2015 Apr 24

PMID 25903820

Citations 29

Authors

Zhiyong Chen

Wei Hu

Yan Wang

Ziwei Guo

Lingyun Sun

Masataka Kuwana

Affiliations

Soon will be listed here.

Abstract

The study aims to comprehensively assess the profiles of myositis-specific autoantibodies (MSAs) in Chinese patients with polymyositis (PM)/dermatomyositis (DM) and compare them with a Japanese cohort. One hundred forty-five Chinese patients (68 classic DM, 25 clinically amyopathic DM [CADM], and 52 PM) and 165 Japanese patients (56 classic DM, 52 CADM, and 57 PM) were recruited. MSAs were measured with immunoprecipitation, enzyme-linked immunosorbent assay, or immunoprecipitation-immunoblotting. MSA frequencies were compared. The overall frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was significantly higher in the Chinese patients than in the Japanese cohort (36.6 % [53/145] versus 15.8 % [26/165], respectively, P < 0.001), whereas the frequencies of anti-signal recognition particle (SRP) antibodies (1.4 % [2/145] versus 7.9 % [13/165], respectively, P = 0.008) and anti-aminoacyl-transfer RNA synthetase (anti-ARS) antibodies (27.6 % [40/145] versus 40 % [66/165], respectively, P = 0.02,) were significantly lower. The significantly lower frequency of anti-ARS antibodies and significantly higher frequency of anti-MDA5 antibodies in the Chinese patients were observed in the classic DM subset (14.7 % [10/68] versus 46.4 % [26/56], respectively, P < 0.001, and 45.6 % [31/68] versus 5.4 % [3/56], respectively, P < 0.001) and CADM subset (8.0 % [2/25] versus 28.8 % [15/52], respectively, P = 0.04, and 88.0 % [22/25] versus 44.2 % [23/52], respectively, P = 0.0002), but not in the PM subset. The first detailed profile of MSAs in Chinese patients with PM/DM was established. The differences in MSA frequencies in the Chinese cohort and Japanese cohort suggest underlying genetic and/or environmental differences between these two populations. Key Messages • A significantly higher frequency of anti-melanoma differentiation-associated gene 5 (MDA5) antibodies was observed in Chinese patients with polymyositis/dermatomyositis (PM/DM) than in Japanese patients. • Our findings suggest that distinct genetic and/or local environmental factors affect Chinese and Japanese patients with PM/DM, who have been considered a "homogeneous" population in previous studies.

Citing Articles

Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases-A Narrative Review.

Kobayashi I Children (Basel). 2024; 11(9).

PMID: 39334579 PMC: 11430821. DOI: 10.3390/children11091046.

A Review of Myositis-Associated Interstitial Lung Disease.

Kannappan R, Kumar R, Cichelli K, Brent L J Clin Med. 2024; 13(14).

PMID: 39064092 PMC: 11278012. DOI: 10.3390/jcm13144055.

Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam.

Ngo D, Le S, Phan K, Doan T, Nguyen L, Dang M J Pathol Transl Med. 2024; 58(4):174-181.

PMID: 38910358 PMC: 11261171. DOI: 10.4132/jptm.2024.05.02.

Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease.

Biddle K, Agaoglu E, Brent G, Adam J, Nockels R, Loveridge A Oxf Med Case Reports. 2024; 2024(6):omae061.

PMID: 38860011 PMC: 11162590. DOI: 10.1093/omcr/omae061.

Epidemiology of the idiopathic inflammatory myopathies.

Khoo T, Lilleker J, Thong B, Leclair V, Lamb J, Chinoy H Nat Rev Rheumatol. 2023; 19(11):695-712.

PMID: 37803078 DOI: 10.1038/s41584-023-01033-0.

References

Sontheimer R . Clinically amyopathic dermatomyositis: what can we now tell our patients?. Arch Dermatol. 2010; 146(1):76-80. DOI: 10.1001/archdermatol.2009.323. View

Chinoy H, Lamb J, Ollier W, Cooper R . Recent advances in the immunogenetics of idiopathic inflammatory myopathy. Arthritis Res Ther. 2011; 13(3):216. PMC: 3218878. DOI: 10.1186/ar3327. View

Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K . Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res Ther. 2011; 13(6):R214. PMC: 3334667. DOI: 10.1186/ar3547. View

Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E . Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis. 2011; 71(6):961-5. PMC: 3371226. DOI: 10.1136/annrheumdis-2011-200182. View

Mimori T, Imura Y, Nakashima R, Yoshifuji H . Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 2007; 19(6):523-9. DOI: 10.1097/BOR.0b013e3282f01a8c. View

Kang E, Kuwana M, Okazaki Y, Lee E, Lee Y, Lee E . Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients. Mod Rheumatol. 2014; 24(6):945-8. DOI: 10.3109/14397595.2014.896494. View

Gono T, Kawaguchi Y, Kuwana M, Sugiura T, Furuya T, Takagi K . Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. Arthritis Rheum. 2012; 64(11):3736-40. DOI: 10.1002/art.34657. View

Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z . Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011; 38(10):973-9. DOI: 10.1111/j.1346-8138.2011.01262.x. View

Qin Qin P, Su F, Xiao Yan W, Xing Z, Meng P, Chengya W . Distribution of human leucocyte antigen-A, -B and -DR alleles and haplotypes at high resolution in the population from Jiangsu province of China. Int J Immunogenet. 2011; 38(6):475-81. DOI: 10.1111/j.1744-313X.2011.01029.x. View

10.

Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183(6):788-824. PMC: 5450933. DOI: 10.1164/rccm.2009-040GL. View

11.

Mammen A . Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 2010; 1184:134-53. DOI: 10.1111/j.1749-6632.2009.05119.x. View

12.

Arnett F, Targoff I, Mimori T, Goldstein R, Warner N, Reveille J . Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 1996; 39(9):1507-18. DOI: 10.1002/art.1780390910. View

13.

Labrador-Horrillo M, Martinez M, Selva-OCallaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M . Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res. 2014; 2014:290797. PMC: 3987881. DOI: 10.1155/2014/290797. View

14.

Furuya T, Hakoda M, Tsuchiya N, Kotake S, Ichikawa N, Nanke Y . Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol. 2004; 31(9):1768-74. View

15.

Chen Z, Cao M, Plana M, Liang J, Cai H, Kuwana M . Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken). 2013; 65(8):1316-24. DOI: 10.1002/acr.21985. View

16.

Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T . RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009; 60(7):2193-200. DOI: 10.1002/art.24621. View

17.

Sato S, Kuwana M . Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010; 22(6):639-43. DOI: 10.1097/BOR.0b013e32833f1987. View